Current and emerging treatment options for myopic choroidal neovascularization
Leila El Matri, Ahmed Chebil, Fedra Kort Department B of Ophthalmology, Hedi Rais Institute of Ophthalmology, Faculty of Medicine of Tunis, University of El Manar, Tunis, Tunisia Abstract: Choroidal neovascularization (CNV) is the main cause of visual impairment in highly myopic patients younger t...
Guardado en:
Autores principales: | El Matri L, Chebil A, Kort F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/005ac5f1dc0446f0aa68ddca5c818d84 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Shatriah I, et al.
Publicado: (2011) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis D, et al.
Publicado: (2017) -
Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
por: Milani P, et al.
Publicado: (2016) -
Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan CS, et al.
Publicado: (2017) -
Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
por: Neeraj Pandey, et al.
Publicado: (2010)